Gate2Brain
  • Home
  • Company
  • Team
  • Technology
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain 2 year highlights at a glance

Publications
2 year anniversaryGate2Brain

This year, to commemorate the 2nd anniversary of our company, we published a corporate booklet summarizing Gate2Brain’s highlights in its first two years of life.

Looking at our publication and video, it both feels like a blink of an eye, and now here we’re! and at the same time like such a hard-earned milestone. They say when you start your business the first year is usually the hardest, and when your first year is 2020? Well, you get the picture!!

Launching Gate2Brain has been quite the roller coaster filled with rewarding highs and hard work times. Despite the tough times, one thing remains crystal clear, how grateful we’re to our team, founders, advisors, investors and collaborators. Their work, expertise and support are bringing us every day one step further to bring medicines beyond barriers.

While here we’re so proud of what our first two years have entailed, most of all, we’re highly motivated and excited about what the future will bring. Growth, challenges, highs and lows, we’ll welcome them with curiosity and enthusiasm.

We invite you to take a look over our first 2 years, our technology, our dream, our team, our highlights, to cut it short, the beginning of a challenging and rewarding journey towards bringing medicines beyond barriers. Enjoy it!

November 9, 2022/by noticias
Tags: anniversary, Gate2Brain, medicinesbeyondbarriers
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/11/Sin-Gate2Brain-2nd-anniversary-1.gif 1712 1210 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-11-09 10:27:182022-11-09 10:31:37Gate2Brain 2 year highlights at a glance
You might also like
Una tecnología para ayudar a tratar el cáncer infantilgate2brainA technology to help treat pediatric cancer
Meritxell Teixidó això de semblar una superwomen em patina moltDiari AraI couldn’t care less about looking like a “superwoman”
medicines beyond barriersG2BMedicines beyond barriers
GATE2BRAIN winner of the Barcelona Activa Pre-acceleration competitionBarcelona ActivaGATE2BRAIN WINNER OF THE BARCELONA ACTIVA PRE-ACCELERATION COMPETITION
Gate2Brain's retreat 2022Gate2BrainGate2Brain’s retreat 2022
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.TransfiereGate2Brain in Transfiere – European Forum for Science, Technology & Innovation
Within the framework of the discussion-based interview series, Exploration Science, in which scientists talk about their ventures and areas of expertise, our CEO, Dr. Meritxell Teixidó, and the first and only APS American Peptide Idol joined @CEM's Dr. Wendy Hartsock to discuss the work @Gate2Brain is doing in pediatric oncology, dive into the technology, and talk about empathetic leadership and the power of diversity.CEMExploration Science with Dr. Wendy Harsock
Technology closer to young patientsG2BTechnology closer to young patients

CATEGORIES

  • Clipping
  • Events
  • Media
  • News
  • Podcast
  • Press releases
  • Publications
  • Videos

Events

  • BioSpain 2023G2BBioSpain 2023September 29, 2023 - 17:51
  • summer retreatGate2Brain’s Summer Retreat 2023July 24, 2023 - 09:42
  • Bits & PretzelsG2BBits & PretzelsJune 22, 2023 - 12:15
  • 17th China International Peptide Academic Symposium17th China International Peptide Academic SymposiumJune 19, 2023 - 09:15
  • Frontiers of Innovation and EntrepreneurshipG2BFrontiers of Innovation and EntrepreneurshipJune 13, 2023 - 10:40

SOCIAL

  • linkedin
  • youtube

RSS RSS Ciencia

  • BCN Health Booster companies complete first year of the program with flying colors September 27, 2023 biocat
  • September picks: Barcelona, benchmark site for international events in the sector September 27, 2023 biocat
  • Presentation of road map to accelerate the adoption of innovation to the Catalan Health System September 27, 2023 biocat
  • 6th edition of CRAASH Barcelona kicks off September 8, 2023 biocat
  • Join us for the second Barcelona Health Innovation Week 2024 September 6, 2023 biocat
  • HIGHLIGHTS: News in CAR-T, Orikine round, Roche investment in Catalonia, first genetic variant for multiple sclerosis July 27, 2023 biocat
  • From medical history to research: European framework for secondary use of health data July 26, 2023 biocat
  • Debate on: Future European Health Data Space July 26, 2023 biocat
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Gordon Research ConferencesGORDON CONFERENCESgate2braindesafio singaporeICEXDesafía Singapore
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}